Thrombotic events following the BNT162b2 mRNA COVID-19 vaccine (Pfizer-BioNTech) in Aotearoa New Zealand: A self-controlled case series study

BACKGROUND: An association between thrombotic events and SARS-CoV-2 infection and the adenovirus-based COVID-19 vaccines has been established, leading to concern over the risk of thrombosis after BNT162b2 COVID-19 vaccination. OBJECTIVES: To evaluate the risk of arterial thrombosis, cerebral venous...

Descripción completa

Detalles Bibliográficos
Autores principales: Walton, Muireann, Tomkies, Robert, Teunissen, Thomas, Lumley, Thomas, Hanlon, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2023
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794399/
https://www.ncbi.nlm.nih.gov/pubmed/36634464
http://dx.doi.org/10.1016/j.thromres.2022.12.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794399/
https://www.ncbi.nlm.nih.gov/pubmed/36634464
http://dx.doi.org/10.1016/j.thromres.2022.12.012

Ejemplares similares